Brauneria purpurea, Echinacea intermedia, Echinacea Purpurea

The essential properties of Echinacea are anti-inflammatory, antioxidants, detoxifying, among others. The consumption of this herb can down the chances of developing a common cold and may reduce the duration of colds by some days. Likewise, research shows that Echinacea have the ability to alleviate the symptoms of depression by stimulating the release of L-DOPA, which is also used to treat Parkinson’s symptoms.

  • Origin: Plant Based
  • Source: Itself
  • Type: Herbs, Roots & Barks
  • Age Range: Adults
  • Toxicity: There is no evidence of toxicity until now
  • Outcomes: Immunity, Immune Booster

What are Echinacea Purpurea benefits?

Echinacea purpurea is a widely used herb for the prevention of the common cold. With studies supporting this use, it also acts to increase the lymphocyte count. In addition, it helps the immune system, reduces anxiety, and has anti-inflammatory properties. Its consumption can be in tea, as an herb, or through capsules for supplementation. Originating in North America, it is part of the sunflower family. Even with its common use only for coughs and flu, we noticed how much this nutraceutical can help us, so be sure to take our test and discover other nutraceuticals that can help your body in several areas!

Table of relations

Consistent effects
Strength of effects
Scientific articles

Immunity Echinacea Purpurea and Immunity

The immune system is made up of cells, tissues and organs that act in the organism's defense against the harmful effects of external microorganisms. The supplements indicated for immunity act as strengthening agents of this system, increasing the antibodies production and, consequently, its defense activity.
  • Immune Booster

    The immune system is responsible for defense against infectious agents, and is composed of leukocytes, macrophages, and lymphocytes. When immunity levels are low, the body is more likely to become infected with viruses, bacteria, and others. People who are easily infected can have low immunity for various reasons, such as family history diseases, poor diet, or absorption difficulties in some body function. Maintaining the intake of substances that strengthen immunity is to prevent diseases and prepare the body for any possible infection. To do this, it is important to turn your attention to what is ingested, exercise habits, and supplementation.

Table of negative interactions

Rasagiline, Tizanidine

Related videos about Echinacea Purpurea


  1. a b Cohen HA, et al. Effectiveness of an herbal preparation containing echinacea, propolis, and vitamin C in preventing respiratory tract infections in children: a randomized, double-blind, placebo-controlled, multicenter studyArch Pediatr Adolesc Med. (2004)
  2. a b Lindenmuth GF, Lindenmuth EB. The efficacy of echinacea compound herbal tea preparation on the severity and duration of upper respiratory and flu symptoms: a randomized, double-blind placebo-controlled studyJ Altern Complement Med. (2000)
  3. ^ Yakoot M, Salem A. Efficacy and safety of a multiherbal formula with vitamin C and zinc (Immumax) in the management of the common coldInt J Gen Med. (2011)
  4. ^ Naser B, et al. A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common coldPhytomedicine. (2005)
  5. ^ Barth A, et al. Antitussive effect of a fixed combination of Justicia adhatoda, Echinacea purpurea and Eleutherococcus senticosus extracts in patients with acute upper respiratory tract infection: A comparative, randomized, double-blind, placebo-controlled studyPhytomedicine. (2015)
  6. ^ Thom E, Wollan T. A controlled clinical study of Kanjang mixture in the treatment of uncomplicated upper respiratory tract infectionsPhyto Res. (1998)
  7. a b Whitehead MT, et al. The effect of 4 wk of oral echinacea supplementation on serum erythropoietin and indices of erythropoietic statusInt J Sport Nutr Exerc Metab. (2007)
  8. ^ Rahmati M, et al. Efficacy and safety of echinacea root extracts in the treatment of pediatric common cold: A randomised clinical trialJ of Maz U Med Sci. (2012)
  9. a b c d e Hermann R, von Richter O. Clinical evidence of herbal drugs as perpetrators of pharmacokinetic drug interactionsPlanta Med. (2012)
  10. a b c Wu L, et al. Echinacea-induced cytosolic Ca2+ elevation in HEK293BMC Complement Altern Med. (2010)
  11. a b c d e f g Dalby-Brown L, et al. Synergistic antioxidative effects of alkamides, caffeic acid derivatives, and polysaccharide fractions from Echinacea purpurea on in vitro oxidation of human low-density lipoproteinsJ Agric Food Chem. (2005)
  12. ^ Najm W, Lie D. Dietary supplements commonly used for preventionPrim Care. (2008)
  13. ^ Ma H, et al. The roles of herbal remedies in survival and quality of life among long-term breast cancer survivors–results of a prospective studyBMC Cancer. (2011)
  14. ^ Bright-Gbebry M, et al. Use of multivitamins, folic acid and herbal supplements among breast cancer survivors: the black women’s health studyBMC Complement Altern Med. (2011)
  15. ^ Engdal S, Klepp O, Nilsen OG. Identification and exploration of herb-drug combinations used by cancer patientsIntegr Cancer Ther. (2009)
  16. ^ Walsh NP, et al. Position statement. Part two: Maintaining immune healthExerc Immunol Rev. (2011)
  17. ^ Senchina DS, et al. Herbal supplements and athlete immune function–what’s proven, disproven, and unprovenExerc Immunol Rev. (2009)
  18. a b c d e f g h i j k Ritchie MR, et al. Effects of Echinaforce® treatment on ex vivo-stimulated blood cellsPhytomedicine. (2011)
  19. a b c d e f g h i j k l m n o p q r s Thomsen MO, et al. Seasonal variations in the concentrations of lipophilic compounds and phenolic acids in the roots of Echinacea purpurea and Echinacea pallidaJ Agric Food Chem. (2012)
  20. a b c d e f g h i Hohmann J, et al. Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptorsPhytochemistry. (2011)
  21. ^ The constituents of Echinacea atrorubens roots and aerial parts.
  22. a b Spelman K, Wetschler MH, Cech NB. Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MSJ Pharm Biomed Anal. (2009)
  23. ^ Bauer R, Remiger P. TLC and HPLC Analysis of Alkamides in Echinacea Drugs1,2Planta Med. (1989)
  24. ^ Alkamides from the roots of Echinacea angustifolia.
  25. ^ Chen Y, et al. Macrophage activating effects of new alkamides from the roots of Echinacea speciesJ Nat Prod. (2005)
  26. a b Lu Y, et al. Efficient counter-current chromatographic isolation and structural identification of two new cinnamic acids from Echinacea purpureaNat Prod Commun. (2012)
  27. a b c d e f g h Benson JM, et al. Echinacea purpurea extracts modulate murine dendritic cell fate and functionFood Chem Toxicol. (2010)
  28. a b Liu Y, et al. Adjuvant activity of Chinese herbal polysaccharides in inactivated veterinary rabies vaccinesInt J Biol Macromol. (2012)
  29. ^ Di Pierro F, et al. Use of a standardized extract from Echinacea angustifolia (Polinacea) for the prevention of respiratory tract infectionsAltern Med Rev. (2012)
  30. ^ Ragupathi G, et al. Evaluation of widely consumed botanicals as immunological adjuvantsVaccine. (2008)
  31. ^ TLC and HPLC Analysis of Alkamides in Echinacea Drugs.
  32. ^ Chicca A, et al. Cytotoxic activity of polyacetylenes and polyenes isolated from roots of Echinacea pallidaBr J Pharmacol. (2008)
  33. a b Binns SE, et al. Phytochemical variation in echinacea from roots and flowerheads of wild and cultivated populationsJ Agric Food Chem. (2002)
  34. ^ Rininger JA, et al. Immunopharmacological activity of Echinacea preparations following simulated digestion on murine macrophages and human peripheral blood mononuclear cellsJ Leukoc Biol. (2000)
  35. a b c d e Pugh ND, et al. The majority of in vitro macrophage activation exhibited by extracts of some immune enhancing botanicals is due to bacterial lipoproteins and lipopolysaccharidesInt Immunopharmacol. (2008)
  36. a b c Pugh ND, Jackson CR, Pasco DS. Total bacterial load within Echinacea purpurea, determined using a new PCR-based quantification method, is correlated with LPS levels and in vitro macrophage activityPlanta Med. (2013)
  37. a b Brinkeborn RM, Shah DV, Degenring FH. Echinaforce and other Echinacea fresh plant preparations in the treatment of the common cold. A randomized, placebo controlled, double-blind clinical trialPhytomedicine. (1999)
  38. a b Kim HO, et al. Retention of alkamides in dried Echinacea purpureaJ Agric Food Chem. (2000)
  39. ^ Kim HO, et al. Retention of caffeic acid derivatives in dried Echinacea purpureaJ Agric Food Chem. (2000)
  40. ^ Stuart DL, Wills RB. Effect of drying temperature on alkylamide and cichoric acid concentrations of Echinacea purpureaJ Agric Food Chem. (2003)
  41. a b Livesey J, et al. Effect of temperature on stability of marker constituents in Echinacea purpurea root formulationsPhytomedicine. (1999)
  42. a b Effect of handling and storage on alkylamides and cichoric acid in Echinacea purpurea.
  43. ^ Patterson MF. Microbiology of pressure-treated foodsJ Appl Microbiol. (2005)
  44. ^ Chen XM, et al. Effect of high pressure pasteurization on bacterial load and bioactivity of Echinacea purpureaJ Food Sci. (2010)
  45. ^ Advantages of high pressure sterilisation on quality of food products.
  46. ^ Schapowal A. Efficacy and safety of Echinaforce® in respiratory tract infectionsWien Med Wochenschr. (2013)
  47. a b Woelkart K, et al. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interaction with the immune systemInt J Clin Pharmacol Ther. (2006)
  48. a b c d e f Gertsch J, et al. Echinacea alkylamides modulate TNF-alpha gene expression via cannabinoid receptor CB2 and multiple signal transduction pathwaysFEBS Lett. (2004)
  49. a b c d e f g Shah SA, et al. Evaluation of echinacea for the prevention and treatment of the common cold: a meta-analysisLancet Infect Dis. (2007)
  50. a b Matthias A, et al. Permeability studies of alkylamides and caffeic acid conjugates from echinacea using a Caco-2 cell monolayer modelJ Clin Pharm Ther. (2004)
  51. ^ Jager H, et al. Transport of alkamides from Echinacea species through Caco-2 monolayersPlanta Med. (2002)
  52. a b Matthias A, et al. Bioavailability of Echinacea constituents: Caco-2 monolayers and pharmacokinetics of the alkylamides and caffeic acid conjugatesMolecules. (2005)
  53. a b Matthias A, et al. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomesChem Biol Interact. (2005)
  54. a b Woelkart K, et al. Bioavailability and pharmacokinetics of alkamides from the roots of Echinacea angustifolia in humansJ Clin Pharmacol. (2005)
  55. ^ Matthias A, et al. Echinacea alkamide disposition and pharmacokinetics in humans after tablet ingestionLife Sci. (2005)
  56. ^ Goey AK, et al. The bioanalysis of the major Echinacea purpurea constituents dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobutylamides in human plasma using LC-MS/MSJ Chromatogr B Analyt Technol Biomed Life Sci. (2012)
  57. a b c Gorski JC, et al. The effect of echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivoClin Pharmacol Ther. (2004)
  58. a b Gurley BJ, et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium, Echinacea purpurea, milk thistle, and saw palmettoClin Pharmacol Ther. (2004)
  59. ^ Gurley BJ, et al. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John’s wort, and EchinaceaMol Nutr Food Res. (2008)
  60. a b Moltó J, et al. Herb-drug interaction between Echinacea purpurea and darunavir-ritonavir in HIV-infected patientsAntimicrob Agents Chemother. (2011)
  61. ^ Penzak SR, et al. Echinacea purpurea significantly induces cytochrome P450 3A activity but does not alter lopinavir-ritonavir exposure in healthy subjectsPharmacotherapy. (2010)
  62. ^ Abdul MI, et al. Pharmacokinetic and pharmacodynamic interactions of echinacea and policosanol with warfarin in healthy subjectsBr J Clin Pharmacol. (2010)
  63. ^ Wittkowsky AK. Warfarin and other coumarin derivatives: pharmacokinetics, pharmacodynamics, and drug interactionsSemin Vasc Med. (2003)
  64. ^ Mahringer A, et al. Alkamides from Echinacea angustifolia Interact with P-Glycoprotein of Primary Brain Capillary Endothelial Cells Isolated from Porcine Brain Blood VesselsPlanta Med. (2013)
  65. ^ Qiang Z, et al. Echinacea sanguinea and Echinacea pallida Extracts Stimulate Glucuronidation and Basolateral Transfer of Bauer Alkamides 8 and 10 and Ketone 24 and Inhibit P-glycoprotein Transporter in Caco-2 CellsPlanta Med. (2013)
  66. ^ Woelkart K, et al. The endocannabinoid system as a target for alkamides from Echinacea angustifolia rootsPlanta Med. (2005)
  67. ^ Chicca A, et al. Synergistic immunomopharmacological effects of N-alkylamides in Echinacea purpurea herbal extractsInt Immunopharmacol. (2009)
  68. a b Raduner S, et al. Alkylamides from Echinacea are a new class of cannabinomimetics. Cannabinoid type 2 receptor-dependent and -independent immunomodulatory effectsJ Biol Chem. (2006)
  69. a b Woelkart K, Bauer R. The role of alkamides as an active principle of echinaceaPlanta Med. (2007)
  70. ^ Haller J, et al. The effects of genetic and pharmacological blockade of the CB1 cannabinoid receptor on anxietyEur J Neurosci. (2002)
  71. ^ Gertsch J. Immunomodulatory lipids in plants: plant fatty acid amides and the human endocannabinoid systemPlanta Med. (2008)
  72. ^ Piomelli D, et al. Pharmacological profile of the selective FAAH inhibitor KDS-4103 (URB597)CNS Drug Rev. (2006)
  73. a b Haller J, et al. The anxiolytic potential and psychotropic side effects of an echinacea preparation in laboratory animals and healthy volunteersPhytother Res. (2013)
  74. ^ Shah SA, et al. Effects of echinacea on electrocardiographic and blood pressure measurementsAm J Health Syst Pharm. (2007)
  75. ^ Pertwee RG. The pharmacology of cannabinoid receptors and their ligands: an overviewInt J Obes (Lond). (2006)
  76. ^ Goel V, et al. Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal ratsInt Immunopharmacol. (2002)
  77. a b Sullivan AM, et al. Echinacea-induced macrophage activationImmunopharmacol Immunotoxicol. (2008)
  78. ^ Stevenson LM, et al. Modulation of macrophage immune responses by EchinaceaMolecules. (2005)
  79. ^ Tamta H, et al. Variability in in vitro macrophage activation by commercially diverse bulk echinacea plant material is predominantly due to bacterial lipoproteins and lipopolysaccharidesJ Agric Food Chem. (2008)
  80. ^ Rossol M, et al. LPS-induced cytokine production in human monocytes and macrophagesCrit Rev Immunol. (2011)
  81. a b Senchina DS, et al. Phytochemical and immunomodulatory properties of an Echinacea laevigata (Asteraceae) tinctureJ Altern Complement Med. (2011)
  82. ^ Kapai NA, et al. Selective cytokine-inducing effects of low dose EchinaceaBull Exp Biol Med. (2011)
  83. ^ Skopińska-Rózewska E, et al. Dose-dependent in vivo effect of Rhodiola and Echinacea on the mitogen-induced lymphocyte proliferation in micePol J Vet Sci. (2011)
  84. a b Zhai Z, et al. Enhancement of innate and adaptive immune functions by multiple Echinacea speciesJ Med Food. (2007)
  85. a b c Sasagawa M, et al. Echinacea alkylamides inhibit interleukin-2 production by Jurkat T cellsInt Immunopharmacol. (2006)
  86. ^ Mishima S, et al. Antioxidant and immuno-enhancing effects of Echinacea purpureaBiol Pharm Bull. (2004)
  87. ^ Morazzoni P, et al. In vitro and in vivo immune stimulating effects of a new standardized Echinacea angustifolia root extract (Polinacea)Fitoterapia. (2005)
  88. ^ Schwarz E, et al. Effect of oral administration of freshly pressed juice of Echinacea purpurea on the number of various subpopulations of B- and T-lymphocytes in healthy volunteers: results of a double-blind, placebo-controlled cross-over studyPhytomedicine. (2005)
  89. a b Banchereau J, et al. Immunobiology of dendritic cellsAnnu Rev Immunol. (2000)
  90. a b Wang CY, et al. Modulatory effects of Echinacea purpurea extracts on human dendritic cells: a cell- and gene-based studyGenomics. (2006)
  91. ^ Wang CY, et al. Genomics and proteomics of immune modulatory effects of a butanol fraction of echinacea purpurea in human dendritic cellsBMC Genomics. (2008)
  92. ^ Dong GC, et al. Blocking effect of an immuno-suppressive agent, cynarin, on CD28 of T-cell receptorPharm Res. (2009)
  93. ^ Yin SY, et al. Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: revealed by genomic and proteomic analysesBMC Genomics. (2010)
  94. ^ Yu D, et al. Anti-inflammatory effects of essential oil in Echinacea purpurea LPak J Pharm Sci. (2013)
  95. ^ Rehman J, et al. Increased production of antigen-specific immunoglobulins G and M following in vivo treatment with the medicinal plants Echinacea angustifolia and Hydrastis canadensisImmunol Lett. (1999)
  96. a b Woelkart K, Linde K, Bauer R. Echinacea for preventing and treating the common coldPlanta Med. (2008)
  97. a b Schoop R, et al. Echinacea in the prevention of induced rhinovirus colds: a meta-analysisClin Ther. (2006)
  98. a b c Linde K, et al. Echinacea for preventing and treating the common coldCochrane Database Syst Rev. (2006)
  99. ^ Jadad AR, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessaryControl Clin Trials. (1996)
  100. a b Taylor JA, et al. Efficacy and safety of echinacea in treating upper respiratory tract infections in children: a randomized controlled trialJAMA. (2003)
  101. ^ Sperber SJ, et al. Echinacea purpurea for prevention of experimental rhinovirus coldsClin Infect Dis. (2004)
  102. ^ Turner RB, et al. An evaluation of Echinacea angustifolia in experimental rhinovirus infectionsN Engl J Med. (2005)
  103. ^ Influence of Echinacin (EC31) treatment on the exercise-induced immune response in athletes.
  104. ^ Grimm W, Müller HH. A randomized controlled trial of the effect of fluid extract of Echinacea purpurea on the incidence and severity of colds and respiratory infectionsAm J Med. (1999)
  105. ^ Jawad M, et al. Safety and Efficacy Profile of Echinacea purpurea to Prevent Common Cold Episodes: A Randomized, Double-Blind, Placebo-Controlled TrialEvid Based Complement Alternat Med. (2012)
  106. ^ Schulten B, et al. Efficacy of Echinacea purpurea in patients with a common cold. A placebo-controlled, randomised, double-blind clinical trialArzneimittelforschung. (2001)
  107. ^ Barrett BP, et al. Treatment of the common cold with unrefined echinacea. A randomized, double-blind, placebo-controlled trialAnn Intern Med. (2002)
  108. ^ Petróczi A, et al. Limited agreement exists between rationale and practice in athletes’ supplement use for maintenance of health: a retrospective studyNutr J. (2007)
  109. ^ Gleeson M, Lancaster GI, Bishop NC. Nutritional strategies to minimise exercise-induced immunosuppression in athletesCan J Appl Physiol. (2001)
  110. ^ Gleeson M, Nieman DC, Pedersen BK. Exercise, nutrition and immune functionJ Sports Sci. (2004)
  111. ^ Schoop R, Büechi S, Suter A. Open, multicenter study to evaluate the tolerability and efficacy of Echinaforce Forte tablets in athletesAdv Ther. (2006)
  112. ^ Hall H, Fahlman MM, Engels HJ. Echinacea purpurea and mucosal immunityInt J Sports Med. (2007)
  113. ^ O’Neill W, McKee S, Clarke AF. Immunological and haematinic consequences of feeding a standardised Echinacea (Echinacea angustifolia) extract to healthy horsesEquine Vet J. (2002)
  114. a b c Whitehead MT, et al. Running economy and maximal oxygen consumption after 4 weeks of oral Echinacea supplementationJ Strength Cond Res. (2012)
  115. ^ Szołomicki J, et al. The influence of active components of Eleutherococcus senticosus on cellular defence and physical fitness in manPhytother Res. (2000)
  116. ^ Di Carlo G, et al. Effect on prolactin secretion of Echinacea purpurea, hypericum perforatum and Eleutherococcus senticosusPhytomedicine. (2005)
  117. ^ Dragland S, et al. Several culinary and medicinal herbs are important sources of dietary antioxidantsJ Nutr. (2003)
  118. ^ Free-radical scavenging capacity and antioxidant activity of selected plant species from the Canadian prairies.
  119. ^ Antioxidant Activity and Total Phenolics in Selected Fruits, Vegetables, and Grain Products.
  120. ^ Antioxidant activity of extracts of phenolic compounds from selected plant species.
  121. ^ Screening of radical scavenging activity of some medicinal and aromatic plant extracts.
  122. a b Antioxidant activity of cichoric acid and alkamides from Echinacea purpurea, alone and in combination.
  123. ^ Sharma M, Schoop R, Hudson JB. The efficacy of Echinacea in a 3-D tissue model of human airway epitheliumPhytother Res. (2010)
  124. ^ Goel V, et al. Echinacea stimulates macrophage function in the lung and spleen of normal ratsJ Nutr Biochem. (2002)
  125. ^ Fusco D, et al. Echinacea purpurea aerial extract alters course of influenza infection in miceVaccine. (2010)
  126. ^ Bodinet C, et al. Effect of oral application of an immunomodulating plant extract on Influenza virus type A infection in micePlanta Med. (2002)
  127. ^ Uluışık D, Keskin E. Effects of ginseng and echinacea on cytokine mRNA expression in ratsScientificWorldJournal. (2012)
  128. a b c d Yamada K, et al. A comparison of the immunostimulatory effects of the medicinal herbs Echinacea, Ashwagandha and BrahmiJ Ethnopharmacol. (2011)
  129. ^ Spasov AA, et al. Comparative controlled study of Andrographis paniculata fixed combination, Kan Jang and an Echinacea preparation as adjuvant, in the treatment of uncomplicated respiratory disease in childrenPhytother Res. (2004)
  130. ^ Posadzki P, Watson LK, Ernst E. Adverse effects of herbal medicines: an overview of systematic reviewsClin Med. (2013)
  131. ^ Huntley AL, Thompson Coon J, Ernst E. The safety of herbal medicinal products derived from Echinacea species: a systematic reviewDrug Saf. (2005)
  132. ^ Askeroglu U, Alleyne B, Guyuron B. Pharmaceutical and herbal products that may contribute to dry eyesPlast Reconstr Surg. (2013)
  133. ^ [No authors listed. Don’t take echinacea if you’re allergic to ragweedConsum Rep. (2012)
  134. ^ Mullins RJ. Echinacea-associated anaphylaxisMed J Aust. (1998)
  135. ^ Mullins RJ, Heddle R. Adverse reactions associated with echinacea: the Australian experienceAnn Allergy Asthma Immunol. (2002)
  136. Barrett B, et al. Echinacea for treating the common cold: a randomized trialAnn Intern Med. (2010)
  137. O’Neil J, et al. Effects of echinacea on the frequency of upper respiratory tract symptoms: a randomized, double-blind, placebo-controlled trialAnn Allergy Asthma Immunol. (2008)
  138. Tiralongo E, et al. Randomised, double blind, placebo-controlled trial of echinacea supplementation in air travellersEvid Based Complement Alternat Med. (2012)
  139. Goel V, et al. A proprietary extract from the echinacea plant (Echinacea purpurea) enhances systemic immune response during a common coldPhytother Res. (2005)
  140. Melchart D, et al. Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trialArch Fam Med. (1998)
  141. Goel V, et al. Efficacy of a standardized echinacea preparation (Echinilin) for the treatment of the common cold: a randomized, double-blind, placebo-controlled trialJ Clin Pharm Ther. (2004)
  142. Yale SH, Liu K. Echinacea purpurea therapy for the treatment of the common cold: a randomized, double-blind, placebo-controlled clinical trialArch Intern Med. (2004)
  143. Turner RB, Riker DK, Gangemi JD. Ineffectiveness of echinacea for prevention of experimental rhinovirus coldsAntimicrob Agents Chemother. (2000)
  144. David S, Cunningham R. Echinacea for the prevention and treatment of upper respiratory tract infections: A systematic review and meta-analysisComplement Ther Med. (2019)